Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects

Clinical trial NCT02084810 · WITHDRAWN

Trial details

NCT number: NCT02084810
Sponsor: Novo Nordisk A/S
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A Haemophilia A With Inhibitors Haemophilia B Haemophilia B With Inhibitors Healthy

Start date: 2014-03-01
Primary completion: 2014-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.